rxstat › Shortages › Pramipexole Dihydrochloride

Pramipexole Dihydrochloride (Mirapex) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 29, 2026

Pramipexole Dihydrochloride has no current shortage reported in Canada. It has been in shortage before; the history is below.

A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.

Products affected
0 / 40
Reports on file
136

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
ACT PRAMIPEXOLE
0.25MG · TABLET · TEVA CANADA LIMITED
DIN 02297302 · ended Oct 29, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PRAMIPEXOLE
0.25MG · TABLET · APOTEX INC
DIN 02292378 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PRAMIPEXOLE
0.5MG · TABLET · APOTEX INC
DIN 02292386 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PRAMIPEXOLE
1.0MG · TABLET · APOTEX INC
DIN 02292394 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-PRAMIPEXOLE
1.5MG · TABLET · APOTEX INC
DIN 02292408 · ended Sep 17, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRAPEX
0.25MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02237145 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRAPEX
0.125MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02297256 · ended May 8, 2026 · Disruption of the manufacture of the drug.
Resolved
ACT PRAMIPEXOLE
1.5MG · TABLET · TEVA CANADA LIMITED
DIN 02297337 · ended Oct 1, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.5MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02309130 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
0.25MG · TABLET · SANIS HEALTH INC
DIN 02367602 · ended Apr 24, 2025 · Disruption of the manufacture of the drug.
Resolved
PRAMIPEXOLE
1.5MG · TABLET · PRO DOC LIMITEE
DIN 02325837 · ended Apr 16, 2025 · Delay in shipping of the drug.
Resolved
SANDOZ PRAMIPEXOLE
1MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02315289 · ended Apr 7, 2025 · Requirements related to complying with good manufacturing practices.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Pramipexole Dihydrochloride. Health Canada has 136 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Pramipexole Dihydrochloride is classified under “DOPAMINERGIC AGENTS” (ATC N04BC).

Recent changes

Common questions

What is Pramipexole Dihydrochloride used for?

A dopamine agonist used to treat Parkinson's disease and restless legs syndrome.

When will Pramipexole Dihydrochloride be back in stock in Canada?

Pramipexole Dihydrochloride has no active shortage; supply is normal per Health Canada reports.

Why is Pramipexole Dihydrochloride in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (dopaminergic agents)

Apomorphine (Kynmobi) Partial shortage 1 of 6 reported products affected Bromocriptine Partial shortage 1 of 2 reported products affected · est. return Nov 13, 2026 Carbidopa Levodopa (Sinemet) Partial shortage 4 of 21 reported products affected · est. return Nov 30, 2026 Entacapone (Comtan) Partial shortage 1 of 5 reported products affected · est. return Jan 31, 2027 Rasagiline (Azilect) Partial shortage 2 of 7 reported products affected · est. return Nov 27, 2026 Ropinirole (Requip) Partial shortage 3 of 23 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.